Dr. Elias Doumit, MD

Dr. Doumit practices at Falkenburg Dialysis in Temple Terrace, Florida.

Dr. Doumit's NPI, 1356428577, was assigned on November 1, 2006. Dr. Doumit graduated from Damascus University Faculty of Medicine in 1992. Dr. Doumit holds Florida license ME98937.

Dr. Doumit's primary practice is Falkenburg Dialysis, at 12662 Telecom Dr, Temple Terrace, FL 33637 in Hillsborough County. The practice phone is (813) 372-1625.

Dr. Doumit's primary practice is Falkenburg Dialysis in Temple Terrace, Florida. Dr. Doumit is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Doumit to 1 more hospital, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doumit practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Doumit's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Doumit is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Doumit's licenses on file in 3 states: Florida, Alabama and Michigan.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Doumit treats.

CMS data shows 968 Medicare services from Dr. Doumit across 8 procedure codes in 2024, for 312 Medicare patients. Medicare paid $104,661 for them.

CMS counts 312 Medicare patients who saw Dr. Doumit in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 3.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Doumit's median patient age at 65, with 51% women.

In 2024, Dr. Doumit wrote 701 Medicare Part D claims for 128 patients. 96% of them were for generic drugs. CMS names the drug for 592 of them, across 18 drugs with 11 or more claims each, at $36,545 in total drug cost. In 2023, CMS named 480 claims across 15 drugs.

Dr. Doumit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Doumit as offering telehealth.

Dmand AI links 2 papers to Dr. Doumit in 2018. 2018 was the busiest year, with 2. Dr. Doumit's most frequent co-authors are Tambi Jarmi, MD, George Makdisi, MD and Hani Wadei, MD.

Dmand AI links Dr. Doumit to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Polycystic Kidney, Autosomal Dominant, Nephritis, Hereditary and Polycystic Kidney Diseases. Biogen sponsors the most, 2.

CMS Open Payments shows 5 general payments to Dr. Doumit from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $150.

Dr. Doumit graduated from Damascus University Faculty of Medicine in 1992.

Dr. Doumit is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.